欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是 分享到:

中国临床药理学与治疗学 ›› 2018, Vol. 23 ›› Issue (8): 841-845.doi: 10.12092/j.issn.1009-2501.2018.08.001

• 专论 •    下一篇

医疗器械临床试验监管存在的问题与对策

李 晓1,刘 洋2,王馨怡1   

  1. 1 CFDA高级研修学院,北京 100073;2 上海健康医学院医疗器械学院,上海 201318
  • 收稿日期:2018-07-02 修回日期:2018-07-22 出版日期:2018-08-26 发布日期:2018-08-28
  • 作者简介:李晓,男,CFDA高级研修学院,培训教师,研究方向:医疗器械监督管理。 Tel:010-63365043 E-mail:lx@cfdaied.org 刘洋,男,上海健康医学院医疗器械学院,讲师,研究方向:医疗器械政策法规与监督管理。 Tel:021-65883181 E-mail:liuyang6000@tom.com 王馨怡,女,CFDA高级研修学院,培训助理,研究方向:医疗器械监督管理。 Tel:010-63429266 E-mail:yx4b@cfdaied.org

Problems and countermeasures in the supervision of clinical trials of medical devices

LI Xiao1, LIU Yang2, WANG Xinyi1   

  1. 1 China Food and Drug Administration Institute of Executive Development, Beijing 100073, China; 2 School of Medical Instrument Shanghai University of Medical &Health Science, Shanghai 201318, China
  • Received:2018-07-02 Revised:2018-07-22 Online:2018-08-26 Published:2018-08-28

摘要:

近年来,我国医疗器械临床试验监管工作取得了一定成效。然而,医疗器械临床试验监管中仍然存在一些问题:如开展临床试验的医疗器械产品数量较多,监管职责不明确,临床试验工作缺乏技术性指导,临床试验申办方、研究者及合同研究组织缺乏合规意识。本文剖析了我国医疗器械临床试验监管层面发现的问题,并立足监管主体给出了解决问题的建议,对医疗器械注册相关方面有一定的指导意义。

关键词: 医疗器械, 临床试验, 监管, 对策

Abstract:

In recent years, China's clinical trial supervision of medical device has achieved certain results. However, there are still some problems in the supervision of medical device clinical trials. For example, there are a large number of medical device products for clinical trials, regulatory responsibilities are not clear, clinical trials lack technical guidance, and clinical trial sponsor, investigator, CRO lack Compliance awareness. This paper analyzes the problems found in the supervision level of medical devices clinical trials in China, and gives some suggestions to solve the problems based on the supervision subjects, which has certain guiding significance for the relevant parties of medical instrument registration.

Key words: medical device, clinical trial, supervision, countermeasure

中图分类号: